The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. To learn more about eligibility and participation call 877-789-6100.
| Protocol # | Description | Phase |
| 08-375 | Phase I/II Study of Neoadjuvant Accelerated Short Course Radiation Therapy with Photons and Capecitabine for Resectable Pancreatic Cancer (View details on clinicaltrial.gov) | Phase II |
| 06-248 | Phase I/II Study of Neoadjuvant Accelerated Short Course Radiation Therapy with Proton Beam and Capecitabine for Resectable Pancreatic Cancer (View details on clinicaltrial.gov) | Phase II |
| 09-114 | Phase I/II Study of Vorinostat in Combination with Radiation Therapy and Infusional 5-FU in Patients with Locally Advanced Adenocarcinoma of the Pancreas (View details on clinicaltrial.gov) | Phase II |
Through our founding membership in the Dana-Farber/Harvard Cancer Center, an NCI-designated Comprehensive Cancer Center, these clinical trials are conducted at the Massachusetts General Hospital Cancer Center and may be available at other partner institutions.
